"Liver Function Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions.
| Descriptor ID |
D008111
|
| MeSH Number(s) |
E01.370.372.460
|
| Concept/Terms |
Liver Function Tests- Liver Function Tests
- Function Test, Liver
- Function Tests, Liver
- Liver Function Test
- Test, Liver Function
- Tests, Liver Function
|
Below are MeSH descriptors whose meaning is more general than "Liver Function Tests".
Below are MeSH descriptors whose meaning is more specific than "Liver Function Tests".
This graph shows the total number of publications written about "Liver Function Tests" by people in this website by year, and whether "Liver Function Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 4 | 4 |
| 2000 | 0 | 3 | 3 |
| 2001 | 1 | 2 | 3 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 2 | 2 |
| 2006 | 2 | 6 | 8 |
| 2007 | 1 | 3 | 4 |
| 2008 | 0 | 2 | 2 |
| 2010 | 0 | 2 | 2 |
| 2011 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 3 | 4 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 5 | 5 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 3 | 3 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver Function Tests" by people in Profiles.
-
ACR Appropriateness Criteria® Abnormal Liver Function Tests. J Am Coll Radiol. 2023 11; 20(11S):S302-S314.
-
Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study. J Hepatol. 2022 03; 76(3):536-548.
-
Presentation, patterns and predictive value of baseline liver tests on outcomes in COVID-19 patients without chronic liver disease. World J Gastroenterol. 2021 Nov 14; 27(42):7350-7361.
-
Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy. Am J Gastroenterol. 2020 11; 115(11):1733-1736.
-
TGR5 signaling mitigates parenteral nutrition-associated liver disease. Am J Physiol Gastrointest Liver Physiol. 2020 02 01; 318(2):G322-G335.
-
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2019 12 14; 394(10215):2184-2196.
-
Autoimmune Pancreatitis. Am J Gastroenterol. 2018 09; 113(9):1301.
-
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2018 03 24; 391(10126):1174-1185.
-
Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature. Leuk Lymphoma. 2018 10; 59(10):2360-2368.
-
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Aliment Pharmacol Ther. 2018 Mar; 47(6):753-762.